Developing new biologics drugs is a complex and time-consuming process, but it also offers the potential to revolutionize the treatment of many diseases. The preclinical phase of drug development is particularly critical for biologics, as it requires a deep understanding of the drug’s molecular structure and function, as well as its potential impact on the body’s immune system.
That’s where Southern Research comes in. We have a team of experienced scientists and technicians with a deep understanding of biologics drug development and the preclinical testing process. We offer a comprehensive range of services to support you at every stage of preclinical development, including:
-
- Target validation and identification
- Assay development and screening
- Lead optimization
- Preclinical toxicology
- Biodistribution and pharmacokinetics
- Immunogenicity assessment
We also have state-of-the-art facilities and equipment to support all aspects of biologics drug development and testing.
Why choose our CRO for preclinical drug development and testing of biologics?
Expertise: We have a team of experienced scientists and technicians with a deep understanding of biologics drug development and the preclinical testing process.
Resources: We have state-of-the-art facilities and equipment to support all aspects of biologics drug development and testing.
Flexibility: We can tailor our services to meet your specific needs and budget.
Speed and efficiency: We are committed to helping our clients accelerate their preclinical work and bring their biologics drugs to market faster.
Contact us today to learn more about how we can help you accelerate your preclinical drug development and testing of biologics.
